Mendor, the Finnish diabetes technology company, has signed a distribution agreement with Merck Serono to cover the United Kingdom diabetes market.
This new partnership adds to the list of distribution agreements Mendor has announced recently.
Mendor’s first product, a blood glucose meter the Mendor Discreet, is a unique device that contains all the necessary components for daily blood glucose measurements: the meter, 25 strips and a lancing device in an integrated, stylish device the size of a mobile phone. Mendor Discreet is designed to simplify the lives of people with diabetes who regularly need to test their blood glucose levels.
With the Mendor Discreet blood glucose meter, the patient also gets a license for the Mendor Balance, an advanced cloud‐based self‐care application. Mendor Balance lets people with diabetes see the full picture of their treatment, and helps in recognizing and setting personalized improvement targets. The data produced by the application also gives health care professionals a solid evidence‐based platform for discussion with the patient.
Mendor and Merck Serono are aim to launch in the British market this March at the Diabetes UK exhibition in Glasgow where healthcare professionals will be able to see first‐hand this new easy‐to‐use, highly portable and integrated device. You will be able to talk to healthcare providers about this meter from April onwards and we’ll keep you informed as to progress as to obtaining one.
Mendor’s CEO Kristian Ranta comments, “We are thrilled to have such a great partnership in place with a true global frontrunner in diabetes care ‐ Merck Serono. We are looking forward to building a better future for people with diabetes together with solid partners such as Merck Serono.”
Founded in 2006 in Helsinki, Finland, Mendor develops, manufactures and markets innovative diabetes management products.
Read more and see video about the meter here.
